Journal Title: Advanced Technologies and Translational Multi-Omics in Exact Remedical Application
Aims and Scope:
Advanced Technologies and Translational Multi-Omics in Exact Remedical Application (ATOM-ERA) serves as an international platform for advancing research and collaboration at the intersection of serves to accelerate the clinical translation of multi-omics technologies by publishing rigorous, reproducible, and impactful research that bridges laboratory discovery and patient care. The journal promotes interdisciplinary collaboration among computational scientists, biomedical researchers, and clinicians.
Abbreviated Title: Adv. Technol. Transl. Multi-Omics Exact Remed. Appl
Language: English
Publication Frequency:
Four issues per year, with a continuous online publication model, allowing accepted articles to be published promptly throughout the year.
Open Access:
ATOM-ERA is a fully open-access journal, ensuring unrestricted global access to all published articles and fostering broad dissemination of knowledge.
Publication Fee:
ATOM-ERA does not charge authors any submission, processing, or publication fees.
Plagiarism Check:
All submissions undergo stringent plagiarism screening using reputable detection software to ensure originality and academic integrity.
Review Policy:
All manuscripts are evaluated through a rigorous double-blind peer review process conducted by experts in relevant domains.
Copyright and Licensing:
Published articles are distributed under Creative Commons licenses, permitting wide reuse and distribution with proper attribution to the original authors.
Online ISSN: To be assigned
Editorial Board:
The Editorial Board consists of internationally recognized scholars and professionals spanning genetic, cell and molecular biology, bioinformatics, artificial intelligence, clinical research, computational modeling, and intelligent systems.
Submission Guidelines:
Comprehensive author guidelines are provided to ensure a smooth, transparent, and efficient submission and review process.
Ethical Standards:
ATOM-ERA adheres to the highest ethical standards in scholarly publishing, in line with the principles of COPE and other leading publishing bodies.
Key Features of Advanced Technologies and Translational Multi-Omics in Exact Remedical Application (ATOM-ERA)
Interdisciplinary Perspective:
ATOM-ERA serves as a premier platform for researchers, clinicians, and bioinformaticians to disseminate high-impact translational research. The journal prioritizes studies that demonstrate clear clinical applicability, robust multi-omics integration frameworks, and innovative computational methodologies.
Rigorous Peer Review:
All submissions undergo a thorough double-blind peer review to ensure scientific rigor, relevance, and originality.
Broad Thematic Coverage:
The journal welcomes research on topics including (but not limited to) Advanced technologies in diagnosis and treatment,Translational Multi-Omics,Precision medicine, Methodology,Ethics & Policy, Advanced digital and intelligent technologies in relation to exact diagnosis and treatment.
Ethical and Scientific Integrity:
ATOM-ERA upholds transparency, fairness, and responsibility in all stages of the publication process.
Global Scholarly Community:
Beyond publishing research, ATOM-ERA cultivates an international network of researchers and practitioners working on next-generation Multi-Omics and advanced technologies.
Author-Focused Philosophy:
Authors receive clear guidance, constructive feedback, and professional editorial support throughout the submission and publication lifecycle.
Advanced Technologies and Translational Multi-Omics in Exact Remedical Application (ATOM-ERA) invites researchers, practitioners, and thought leaders from both established and emerging fields to contribute high-quality work that deepens our understanding of Multi-Omics and drives the development of intelligent systems.
